Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05199480 · ClinicalTrials.gov registry record · Early Phase 1
Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health
A Early Phase 1 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 4
- Enrollment target
NCT05199480 is a Early Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 4 participants.
The verdict
NCT05199480, a Early Phase 1 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
Over the last decade, e-cigarettes have become increasingly popular, due to their promotion as a healthy alternative to traditional tobacco cigarettes. However, there are large discrepancies of knowledge in understanding how these e-cigarettes affect the user's health. The overall goal of this study is to evaluate the impact of e-cigarettes usage on user's cardiopulmonary health
Interventions
- DRUG Tobacco flavored liquid type 1
- DRUG Tobacco flavored liquid type 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-01-10 |
| Est. Completion | 2024-07-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05199480
The ClinicalTrials.gov registry entry for NCT05199480 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tobacco flavored liquid type 1 is the first listed.
NCT05199480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05199480 about?
NCT05199480 is a clinical study titled "Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health". Over the last decade, e-cigarettes have become increasingly popular, due to their promotion as a healthy alternative to traditional tobacco cigarettes. However, there are large discrepancies of knowledge in understanding how these e-cigarettes affect the user's health. The overall goal of this study...
What is the current status of trial NCT05199480?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2022-01-10. Estimated completion is 2024-07-30.
What interventions are being tested in trial NCT05199480?
The interventions under investigation include: Tobacco flavored liquid type 1 (DRUG), Tobacco flavored liquid type 2 (DRUG).
Who is sponsoring clinical trial NCT05199480?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.